Tag : cannabinoid CBD

Cannabis News Hemp News Market Watch

Canopy Growth Invests C$429 million to Acquire IP Advancements from Ebbu, Inc.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced this morning that the company has agreed with Ebbu, Inc. to acquire IP and R&D advancements in exchange for C$429 million dollars in cash and stock. Canopy Growth Corp. believes that the acquisition will benefit a number of different vertically integrated assests...

DEA Gives CBD Derived Pharmaceutical, Epidiolex, Approval as a Schedule V Drug

The Drug Enforcement Administration (DEA) has given the Cannabidiol (CBD) derived pharmaceutical product, Epidiolex, a reported Schedule V status. The newly approved drug is an oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The CBD product Epidiolex is derived from the cannabis...